AbCellera Biologics Inc vs Oatly Group AB - ADR — how do they compare? AbCellera Biologics Inc trades at $9.25 (market cap $2.99B), while Oatly Group AB - ADR trades at $12.93 (market cap $415.98M). The key difference: AbCellera Biologics Inc is far larger — about 7.2× Oatly Group AB - ADR's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals.
| ABCL | OTLY | |
|---|---|---|
Market Cap | $2.99B | $415.98M |
Sector | Health | Consumer Staples |
52-Week High | $9.76 | $18.54 |
52-Week Low | $2.78 | $8.03 |
Enterprise Value | $2.58B | $920.39M |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →